QUOTE AND NEWS
Market Intelligence Center  May 18  Comment 
S&P Biotech SPDR (XBI) is an excellent choice for either a diagonal spread or a covered call expiring in Sep. '15 at the $225.00 level according to MarketIntelligenceCenter.com's patented algorithms. A covered call on S&P Biotech SPDR for a net...
Market Intelligence Center  May 15  Comment 
S&P Biotech SPDR (XBI) presents a trading opportunity that offers a 6.57% return in just 126 days. A covered call on S&P Biotech SPDR at the $225.00 level expiring on Sep. '15 offers an assigned return rate of 6.57% or 19.05% annualized. This...
Forbes  May 11  Comment 
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1% on the day. Components of that ETF showing particular strength include shares of Keryx Biopharmaceuticals (KERX), up about 10.1% and shares of Idera...
Forbes  May 8  Comment 
In trading on Friday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Alder Biopharmaceuticals (ALDR), up about 18% and shares of Xoma...
Forbes  May 6  Comment 
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Synageva Biopharma (GEVA), up about 115.3% and shares of Progenics...
Forbes  Apr 27  Comment 
In trading on Monday, the Junior Gold Miners ETF (GDXJ) is outperforming other ETFs, up about 3.2% on the day.  Components of that ETF showing particular strength include shares of Coeur Mining (CDE), up about 8.8% and shares of Silver Standard...
Market Intelligence Center  Apr 15  Comment 
S&P Biotech SPDR (XBI) closed Tuesday at $231.90 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities...
Forbes  Apr 13  Comment 
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.8% on the day.  Components of that ETF showing particular strength include shares of Clovis Oncology (CLVS), up about 13.6% and shares of Incyte Genomics...
Forbes  Apr 1  Comment 
In trading on Wednesday, the Junior Gold Miners ETF (GDXJ) is outperforming other ETFs, up about 4.5% on the day.  Components of that ETF showing particular strength include shares of Bear Creek Mining (BCM.CA), up about 15.4% and shares of...
Forbes  Mar 26  Comment 
In trading on Thursday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 0.5% on the day.  Components of that ETF showing particular strength include shares of Harmony Gold Mining (HMY), up about 3.7% and shares of IAMGOLD (IAG),...




RELATED WIKI ARTICLES
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki